Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Over-the-Counter

Novis PR, Inc.: Pecgen DMX Cough Suppressant Recalled Due to Incorrect Dosage Instructions

Agency Publication Date: June 10, 2019
Share:
Sign in to monitor this recall

Summary

Novis PR, Inc. is recalling approximately 5,766 bottles of Pecgen DMX Cough Suppressant Expectorant (guaifenesin, dextromethorphan, and phenylephrine) because the drug facts label contains a typographical error regarding dosage. The label incorrectly provides dosage instructions for children as young as 6 months to under 2 years of age, when it was intended for children ages 6 to under 12. This error could lead to young children receiving an incorrect and potentially dangerous amount of the medication. The 16-ounce bottles were distributed throughout Puerto Rico.

Risk

Caregivers following the incorrect label may provide an adult-strength dosage to infants and toddlers as young as 6 months old. This creates a high risk of accidental overdose, which can lead to serious adverse health effects in young children, especially since the label also fails to advise consulting a doctor for children under 2 years of age.

What You Should Do

  1. Check your medicine cabinet for 16-ounce (474 mL) bottles of Pecgen DMX Cough Suppressant Expectorant with NDC number 52083-630-16.
  2. Verify the lot number and expiration date on the side of the bottle. Affected products include lot D80202 or D80210 with expiration date 02/20, and lots D80818, D80819, or D80820 with expiration date 09/20.
  3. Immediately stop using the product if it matches any of these lot numbers, and do not administer it to children.
  4. Contact your healthcare provider or pharmacist for guidance on alternative treatments and to discuss any health concerns if the product has already been used.
  5. Return any unused portion of the recalled medication to the pharmacy or place of purchase for a full refund.
  6. For further questions or to report a health issue, contact the FDA Consumer Complaint coordinator at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: Pecgen DMX Cough Suppressant Expectorant (16 Fl. oz. / 474 mL)
Model:
NDC 52083-630-16
Lot Numbers:
D80202 (Exp. 02/20)
D80210 (Exp. 02/20)
D80818 (Exp. 09/20)
D80819 (Exp. 09/20)
D80820 (Exp. 09/20)
Date Ranges: Expiration 02/20, Expiration 09/20

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 82968
Status: Resolved
Manufacturer: Novis PR, Inc.
Sold By: Kramer Novis; Pharmacies in Puerto Rico
Manufactured In: United States
Units Affected: 5766 bottles
Distributed To: Puerto Rico
Agency Last Updated: June 19, 2019

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.